The bicomponent pore-forming leucocidins of Staphylococcus aureus - Test2 - elhamkhani - TriplyDB

The bicomponent pore-forming leucocidins of Staphylococcus aureus

The bicomponent pore-forming leucocidins of Staphylococcus aureus

http://www.wikidata.org/entity/Q33743499

about

Antimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureus Staphylococcal manipulation of host immune responses Quorum-sensing regulation in staphylococci-an overview Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation Staphylococcus aureus Pore-Forming Toxins.The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH.A novel pore-forming toxin in type A Clostridium perfringens is associated with both fatal canine hemorrhagic gastroenteritis and fatal foal necrotizing enterocolitis.Autophagy mediates tolerance to Staphylococcus aureus alpha-toxin.Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage.Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular.Bovine Staphylococcus aureus Secretes the Leukocidin LukMF' To Kill Migrating Neutrophils through CCR1.Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors Human Monocyte-Derived Osteoclasts Are Targeted by Staphylococcal Pore-Forming Toxins and Superantigens.Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence.Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies.Staphylococcus aureus Tissue Infection During Sepsis Is Supported by Differential Use of Bacterial or Host-Derived Lipoic Acid.Identification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus.Synergistic Action of Staphylococcus aureus α-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal Sepsis Crystal structures of the components of the Staphylococcus aureus leukotoxin ED.Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis Inhibiting bacterial toxins by channel blockage.Staphylococcus aureus Coordinates Leukocidin Expression and Pathogenesis by Sensing Metabolic Fluxes via RpiRc.Proteomics Analysis Reveals Previously Uncharacterized Virulence Factors in Vibrio proteolyticus.Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893 Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.The Spl Serine Proteases Modulate Staphylococcus aureus Protein Production and Virulence in a Rabbit Model of Pneumonia.Pathogenesis of Staphylococcus aureus Bloodstream Infections.LukMF' is the major secreted leukocidin of bovine Staphylococcus aureus and is produced in vivo during bovine mastitis.Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5.Omics Approaches for the Study of Adaptive Immunity to Staphylococcus aureus and the Selection of Vaccine Candidates.Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.A new approach to toxin neutralization in Staphylococcus aureus therapy.Macrophage cell death in microbial infections.Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.Multivalent Inhibitors of Channel-Forming Bacterial Toxins.

P2860

Q26774998-5C423539-286E-41C7-8005-28E439597680 Q26798461-FFF82B46-86F1-44C6-93EC-51631F0CCE53 Q26823976-B318F647-1CDA-4C28-BC79-FAD3811DDD28 Q30017477-AF1F717C-9DE0-40AA-9121-2CE49123FD5B Q30152755-9F67B76D-0CB7-4820-BA17-9791858C9D97 Q34495209-394B45CE-6E01-41F8-B76D-B81FFBAAA5BA Q34801327-969F91D0-63AE-4676-9E61-B7E5988CEE86 Q35326301-988E5F73-FD58-48C5-AF53-8F885307B78A Q35356667-CE4A86CC-B1DB-46C8-BA78-F59AD11B6371 Q35447430-B37FD732-883F-4910-B72F-F66BE05BA5C1 Q35530119-FCA487E2-959B-4C4D-8DD6-1BFADD4667BC Q35662239-A79C78C3-446B-4DEA-A5F6-C21DFA422F03 Q35715328-472E1F6B-F880-4153-88AF-A39ED9495B66 Q35864500-CAD75841-5C5D-4EC6-978C-749EA3C0CB84 Q35943080-52C7F201-C8A3-4B3F-9AD8-09B5EC5E947C Q36035535-FCA5FF6E-C1E6-456A-B226-6E0503DC3095 Q36081594-8CE97489-DB6E-4E17-A9D9-ECA44B27B248 Q36088381-B10140C4-DC9B-447A-AE4D-5A4A63835939 Q36152845-49158928-92D4-4042-8C44-58B12BFAC675 Q36255105-A2AB5A6E-6C46-40C4-BE64-36456F0C4C6C Q36274821-16BD1CAA-D731-4185-A764-A516EB3CD218 Q36588360-C4B76E4C-A60A-4620-9914-8E087ECB2F7A Q36609408-7509EFA4-08B8-494C-8F2F-0CD079EF136E Q36636170-07AB5DFC-3658-4E92-934B-5C8B8443EA2E Q36794160-F61E8CC1-B8F6-44BA-9A8B-2986E0A1BD10 Q37027315-19FB6895-FCB6-4298-8A39-43A8DC66F5BB Q37168709-06D49BAC-1C84-4B1A-A19E-C621279C48AB Q37203734-C9542F57-4B34-4530-9AD3-7136DFA6931F Q37287845-8960B66A-91F7-42E8-A840-6E4F6DE4C84B Q37287867-9B43CADE-CBF4-43B1-BECF-2DB0699173D9 Q37335319-FAC0BFEE-3EC7-41DF-A533-4D1EDE63B718 Q37347046-CEBDF372-CA94-433B-B48D-B0C74626F6CF Q37441162-E6ABCAD2-A8A6-4BC0-986A-7F4094B5CEA1 Q37502946-D49A9EDE-02E0-43BA-B230-17E8C28B1D22 Q37566435-A1350D1D-3A83-4DC9-AF9A-4F62DC74ECFE Q38235833-D59BB250-ED35-4FC5-A2A8-D549D385BCE4 Q38699896-28B4CAC6-29CC-453B-B85B-6A16170EDB16 Q38718913-0B42A6DC-2236-49E5-8241-0FB0A6C6E013 Q38728618-0CA42B14-62B3-4987-AE66-A5C7A8D12C2B Q38911726-A8A1BD18-CC41-4017-871F-4359D8AD2B05

P2860

The bicomponent pore-forming leucocidins of Staphylococcus aureus

http://www.wikidata.org/entity/Q33743499

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The bicomponent pore-forming leucocidins of Staphylococcus aureus

@ast

The bicomponent pore-forming leucocidins of Staphylococcus aureus

@en

type

label

The bicomponent pore-forming leucocidins of Staphylococcus aureus

@ast

The bicomponent pore-forming leucocidins of Staphylococcus aureus

@en

prefLabel

The bicomponent pore-forming leucocidins of Staphylococcus aureus

@ast

The bicomponent pore-forming leucocidins of Staphylococcus aureus

@en

P1433

Q33743499-43BD6F23-1A2C-4035-A6D7-EF3BB3EA351B

P1476

Q33743499-483F412C-0CEB-4392-B911-513CD3E73316

P2093

Q33743499-67A092B2-26C3-4F71-B2DA-986B51CD0954

P2860

Q33743499-000EFADB-E338-4773-8495-4DEB2CD3CAEE

Q33743499-00F69880-301F-48CB-9CF3-A1A2CEA12DA8

Q33743499-012B36F1-2519-4D42-B0D0-5927136C7992

Q33743499-0178EAF7-C415-4A6F-A81B-45D3573C79DE

Q33743499-018A4D1A-42A0-43A3-A275-5B91026E08F6

Q33743499-01C4ABEF-B47C-43A7-95A0-F52C8A4DADE3

Q33743499-02285E07-7868-438D-913A-533DF4316D37

Q33743499-02A19B08-D9C4-4760-8BCD-6682ED529F56

Q33743499-03E794DB-D6A8-4D29-BCAB-30126A0A1EBF

Q33743499-04DD1B81-CBEA-4DA5-86D4-D2604137BE07

P304

Q33743499-AB004418-3F3B-49C7-9BDB-AA3E10F33826

P31

Q33743499-86BBD58C-91E7-44F7-825F-C2942D7C5574

P356

Q33743499-9B13F606-873C-4165-A385-CA874854ECFB

P433

Q33743499-23FE570A-CCE9-4F09-B441-4D68580F157A

P478

Q33743499-D24596C2-CCA2-45E3-8838-8B78471EC3AC

P50

Q33743499-28C8BC70-1708-4F4B-B0E8-9E3FC13A481B

P577

Q33743499-0AB9943C-B936-4CE4-B092-D19C118F0BD8

P698

Q33743499-EA7AC2CD-9B34-4DDC-915E-A8F4E8305E67

P932

Q33743499-88634F52-1B57-492F-A4D8-A5CE94798F18

P356

P1433

Microbiology and Molecular Biology Reviews

P1476

The bicomponent pore-forming leucocidins of Staphylococcus aureus

@en

P2093

Francis Alonzo

http://www.w3.org/2001/XMLSchema#string

P2860

Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials

Exotoxins of Staphylococcus aureus

Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule

Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic

Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components

Vaccine protection against Staphylococcus aureus pneumonia

Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism

Staphylococcus aureus α-toxin: nearly a century of intrigue

P304

199-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MMBR.00055-13

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Victor J Torres

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24847020

http://www.w3.org/2001/XMLSchema#string

P932

4054254

http://www.w3.org/2001/XMLSchema#string